Skip to main content
Autolus Therapeutics plc (AUTL)
NASDAQ: AUTL · Real-Time Price · USD
1.320
-0.030 (-2.22%)
At close: May 9, 2025, 4:00 PM
1.350
+0.030 (2.27%)
After-hours: May 9, 2025, 5:35 PM EDT

Revenue by Product

Fiscal year is January - December.
Fiscal Year
 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2016 - 2018
Period Ending
 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2016 - 2018
Chimeric Antigen Receptors T Cell Therapies
1.70M
Log In
Log In
Log In
Log In
Upgrade
Chimeric Antigen Receptors T Cell Therapies Growth
-73.30%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2016 - 2018
Period Ending
 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2016 - 2018
United States
1.35M
Log In
Log In
Log In
Log In
Upgrade
United Kingdom
346.00K
Log In
Log In
Log In
Log In
Upgrade
United Kingdom, Europe and United States
-
Log In
Log In
Log In
Log In
Upgrade
United Kingdom, Europe and United States Growth
-
Log In
Log In
Log In
Log In
Upgrade